-
Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
申请人:——
公开号:US20030109687A1
公开(公告)日:2003-06-12
Compounds of the formula
Y
3
(R
4
)—X—Y
1
(R
1
R
2
)-Z-Y
2
(R
2
)-A-B
where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist or retinoid inverse agonist type biological activity.
公式Y3(R4)-X-Y1(R1R2)-Z-Y2(R2)-A-B所表示的化合物具有视黄醇、视黄醇拮抗剂或视黄醇反向激动剂类型的生物活性,其中符号的含义在说明书中定义。
-
Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
申请人:——
公开号:US20030130515A1
公开(公告)日:2003-07-10
Compounds of the formula
1
where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist and/or retinoid inverse-agonist-like biological activity.
具有以下式子1的化合物,在规范中定义的符号具有相应的含义,具有类视黄醇、类视黄醇拮抗剂和/或类视黄醇反向激动剂样生物活性。
-
ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
申请人:Allergan Sales, Inc.
公开号:EP0948478A1
公开(公告)日:1999-10-13
-
ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
申请人:Allergan Sales, Inc.
公开号:EP0948478B1
公开(公告)日:2002-04-10
-
TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
申请人:Allergan Sales, Inc.
公开号:EP0975573A1
公开(公告)日:2000-02-02